Literature DB >> 32569365

Impact of extending the timing of maternal pertussis vaccination on hospitalized infant pertussis in England, 2014 - 2018.

Elise Tessier1, Helen Campbell1, Sonia Ribeiro1, Norman K Fry1, Colin Brown2, Julia Stowe1, Nick Andrews3, Mary Ramsay1, Gayatri Amirthalingam1.   

Abstract

BACKGROUND: In October 2012 a maternal pertussis vaccination program was introduced in England for women between 28 and 32 weeks of pregnancy. In April 2016, the recommended optimal window was extended to 20-32 weeks to improve vaccine coverage and protect preterm infants.This study assesses the impact of offering maternal pertussis vaccination earlier in pregnancy on hospitalized infant pertussis cases.
METHODS: Hospitalized pertussis cases ≤60 days old in England were extracted from Hospital Episode Statistics pre-policy change and post policy change. Data were linked to laboratory-confirmed cases and clinical records were reviewed where cases were not matched. Maternal vaccine status of identified cases was established. Median hospital duration was calculated, and a competing risk survival analysis undertaken to assess multiple factors.
RESULTS: A total of 201 cases were included in the analysis. Of the 151 cases with reported gestational age, the number of hospitalizations amongst full-term infants was 60 cases pre-policy and 62 cases post policy, respectively while preterm cases declined from 20 to 9 (p=0.06). Length of hospital stay did not differ significantly after the policy change. Significantly longer hospital stays were seen in cases aged 0- 4 weeks (median of 3 more days than infants 5-8 weeks), premature infants (median of 4 more days than term infants) and cases with coinfections (median of 1 more day than those without coinfection).
CONCLUSIONS: The number of preterm infants hospitalized with pertussis in England halved after the policy change and preterm infants were no longer over-represented amongst hospitalized cases.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

Entities:  

Keywords:  Maternal pertussis; hospitalization; immunization; vaccine; whooping cough

Year:  2020        PMID: 32569365     DOI: 10.1093/cid/ciaa836

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Effect of pertussis vaccine in pregnancy and COVID-19 pandemic in the cases of wooping cough.

Authors:  María Del Rosario León-Morillo; David Gomez-Pastrana; María Cruz Díaz-Colom; Sonia Quecuty-Vela; Juan Carlos Alados-Arboledas; Carmen Aragón-Fernández
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2022-06-09

Review 2.  Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?

Authors:  Robert Cohen; Marion Ashman; Muhamed-Kheir Taha; Emmanuelle Varon; François Angoulvant; Corinne Levy; Alexis Rybak; Naim Ouldali; Nicole Guiso; Emmanuel Grimprel
Journal:  Infect Dis Now       Date:  2021-05-12

3.  Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants.

Authors:  Maarten M Immink; Mireille N Bekker; Hester E de Melker; Nynke Y Rots; Elisabeth A M Sanders; Nicoline A T van der Maas
Journal:  BMC Infect Dis       Date:  2021-09-03       Impact factor: 3.090

Review 4.  Covid-19 vaccination in pregnancy.

Authors:  Martina L Badell; Carolynn M Dude; Sonja A Rasmussen; Denise J Jamieson
Journal:  BMJ       Date:  2022-08-10

5.  Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-Analyses.

Authors:  Konstantinos Karampatsas; Hannah Davies; Maren Mynarek; Nick Andrews; Paul T Heath; Kirsty Le Doare
Journal:  Clin Infect Dis       Date:  2022-09-30       Impact factor: 20.999

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.